Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

VXRT

Vaxart (VXRT)

Vaxart Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:VXRT
DatumZeitQuelleÜberschriftSymbolFirma
14/01/202519h40AllPennyStocks.comThis California-Based Biotech Found Massive Success Following DSMB ApprovalNASDAQ:VXRTVaxart Inc
14/01/202514h00GlobeNewswire Inc.Vaxart Highlights Progress of COVID-19, Norovirus and Influenza ProgramsNASDAQ:VXRTVaxart Inc
14/01/202501h55GlobeNewswire Inc.Vaxart Announces Favorable DSMB Review of Sentinel Cohort from COVID-19 Phase 2b Clinical TrialNASDAQ:VXRTVaxart Inc
31/12/202422h07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VXRTVaxart Inc
27/12/202415h21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VXRTVaxart Inc
17/12/202422h52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VXRTVaxart Inc
02/12/202422h01GlobeNewswire Inc.Vaxart Completes Enrollment of Sentinel Cohort in Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine CandidateNASDAQ:VXRTVaxart Inc
19/11/202414h00GlobeNewswire Inc.Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VXRTVaxart Inc
13/11/202422h23Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VXRTVaxart Inc
13/11/202422h01GlobeNewswire Inc.Vaxart Provides Business Update and Reports Third Quarter 2024 Financial ResultsNASDAQ:VXRTVaxart Inc
07/11/202414h00GlobeNewswire Inc.Vaxart to Host Third Quarter 2024 Business Update and Financial Results Conference Call on November 13NASDAQ:VXRTVaxart Inc
24/10/202414h00GlobeNewswire Inc.Vaxart to Showcase its COVID-19 and Norovirus Oral Pill Vaccine Candidates at World Vaccine Congress Europe 2024NASDAQ:VXRTVaxart Inc
15/10/202414h00GlobeNewswire Inc.Vaxart to Present Norovirus Data at IDWeek 2024 Underscoring Commitment to Address Significant Unmet NeedNASDAQ:VXRTVaxart Inc
08/10/202422h06Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:VXRTVaxart Inc
08/10/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VXRTVaxart Inc
30/09/202423h20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VXRTVaxart Inc
30/09/202422h12GlobeNewswire Inc.Vaxart Announces Initiation of Sentinel Cohort for Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine CandidateNASDAQ:VXRTVaxart Inc
30/08/202414h00GlobeNewswire Inc.Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VXRTVaxart Inc
28/08/202414h00GlobeNewswire Inc.Vaxart Announces Publication in Vaccines of Preclinical Data Supporting the Potential of its Mucosal Vaccine Technology Platform in Enabling Therapeutic Vaccination for HPV-Related Cervical DysplasiaNASDAQ:VXRTVaxart Inc
08/08/202422h16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VXRTVaxart Inc
08/08/202422h01GlobeNewswire Inc.Vaxart Provides Business Update and Reports Second Quarter 2024 Financial ResultsNASDAQ:VXRTVaxart Inc
02/08/202414h00GlobeNewswire Inc.Vaxart to Host Second Quarter 2024 Business Update and Financial Results Conference Call on August 8NASDAQ:VXRTVaxart Inc
20/06/202412h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VXRTVaxart Inc
17/06/202422h05GlobeNewswire Inc.Vaxart Provides Business UpdateNASDAQ:VXRTVaxart Inc
17/06/202412h02Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:VXRTVaxart Inc
14/06/202412h03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VXRTVaxart Inc
14/06/202401h07GlobeNewswire Inc.Vaxart Announces $40 Million Underwritten Offering of Common StockNASDAQ:VXRTVaxart Inc
13/06/202423h26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VXRTVaxart Inc
13/06/202422h36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VXRTVaxart Inc
13/06/202422h15GlobeNewswire Inc.Vaxart Receives BARDA-Funded Project NextGen Award Valued Up to $453 Million to Conduct a Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine CandidateNASDAQ:VXRTVaxart Inc
 Showing the most relevant articles for your search:NASDAQ:VXRT

Kürzlich von Ihnen besucht

Delayed Upgrade Clock